COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. North Dakota patients with a documented clinical need may be eligible for compounded tirzepatide.
North Dakota’s sparse population and vast distances mean many residents rely on shipped medications. Compounding Finder helps North Dakota patients connect with licensed pharmacies that deliver statewide.
Yes. The North Dakota Board of Pharmacy oversees compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.
.png){kind=spacer}
